Vascular responses to drug-coated balloon angioplasty in lipid-rich vs non-lipid-rich coronary lesions

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

BACKGROUND

Lipid-rich plaques are strongly associated with adverse cardiac events. However, the vascular response of lipid-rich lesions to drug-coated balloon (DCB) angioplasty has not been fully elucidated. This study aimed to compare vascular responses following DCB angioplasty between lipid-rich and non-lipid-rich coronary lesions.

METHODS

This study included patients scheduled for DCB angioplasty for de novo small vessel lesions between February 2021 and April 2024. All patients underwent pre- and post-procedural near-infrared spectroscopy combined with intravascular ultrasound (NIRS-IVUS), along with follow-up coronary angiography and NIRS-IVUS at 8 months. Lesions were categorized as lipid-rich or non-lipid-rich based on the pre-procedural maximum lipid core burden index over 4mm (maxLCBI 4 mm). Changes in plaque volume and maxLCBI 4 mm from post-procedure to the 8-month follow-up, as well as the incidence of late lumen enlargement (LLE), were compared between the two groups.

RESULTS

Forty-six patients were included in the final analysis: 15 in the lipid-rich group and 31 in the non-lipid-rich group. LLE occurred in 27% of the lipid-rich group and 39% of the non-lipid-rich group (P = 0.52). Percent plaque volume showed minimal change in the lipid-rich group (+0.3%), while a significant reduction was observed in the non-lipid-rich group (−3.6%; P = 0.045). Conversely, maxLCBI 4 mm significantly decreased in the lipid-rich group compared with the non-lipid-rich group (−240 vs. −42; P = 0.0030), resulting in comparable values at the 8-month follow-up.

CONCLUSIONS

Despite limited plaque regression, lipid-rich lesions demonstrated favorable vascular responses, including LLE and plaque stabilization, following DCB angioplasty.

This study was registered in the UMIN Clinical Trials Registry (UMIN000043158). https://www.umin.ac.jp/

What is Known

  • Vascular responses, such as vessel enlargement and plaque regression, are frequently observed following drug-coated balloon (DCB) angioplasty, contributing to late lumen enlargement (LLE).

What the Study Adds

  • Plaque regression is less likely to occur in lipid-rich lesions.

  • LLE occurs at a similar rate between lipid-rich and non-lipid-rich lesions.

  • Lipid-rich lesions show a significant reduction in lipid burden.

Article activity feed